GATE NEUROSCIENCES
Gate Neurosciences is a healthcare company that offers neuroscience-related medical services. The company is developing the next-generation of targeted CNS therapies, leveraging precision medicine approaches to develop breakthrough drugs for psychiatric and neurologic diseases. It was founded in 2018 and is headquartered in Carmel, IN, USA.
GATE NEUROSCIENCES
Social Links:
Industry:
Biotechnology Health Care Life Science Medical Pharmaceutical
Founded:
2018-01-01
Address:
Carmel, Indiana, United States
Country:
United States
Website Url:
http://www.gateneuro.com
Total Employee:
1+
Status:
Active
Total Funding:
16.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Nginx Sitelinks Search Box Microsoft Exchange Online
Similar Organizations
BioDelivery Sciences
BioDelivery Sciences is a pharmaceutical company that focuses on pain management and addiction medicine.
bttn
bttn is the future of healthcare distribution. Revolutionizing the way that medical supplies are delivered across the world
Diem Health
Diem connects licensed healthcare professionals with medical facilities to work Per Diem
Encore Dermatology
Encore is a dermatology company that provides prescription therapies and medical devices to dermatologists.
GI Alliance
GI Alliance provides comprehensive gastrointestinal care services.
ManFace
ManFace is a health and wellness company that offers men's facial products.
Mate Fertility
Mate Fertility operates tech-enabled fertility clinics that offer affordable and accessible fertility services.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
NVISION Eye Centers
NVISION Eye Centers is a medical practice company that offers eye care services.
Paragon Biosciences
Paragon Biosciences is a global healthcare company committed to accelerating biomedical research.
Portal Instruments
Portal Instruments is an early stage company that offers medical device.
Radicle Science
Radicle Science is a health tech company that offers an accelerated, non-FDA route to drug validation.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Vytal Health
Vytal Health offers integrative and functional medicine services.
Current Employees Featured
Founder
Official Site Inspections
http://www.gateneuro.com Semrush global rank: 5.61 M Semrush visits lastest month: 1.51 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Gate Neurosciences"
Gate Neurosciences - About Us
We're on a mission to answer the unmet needs of people living with CNS conditions by developing safe, potent, and rapid-acting therapies.See details»
Gate Neurosciences - Reimagining Brain Health
May 15, 2024 Gate Neurosciences is a clinical-stage biotechnology company using precision medicine to develop a new generation of therapies that enhance synaptic function for the 1 billion people globally suffering from brain health …See details»
Gate Neurosciences - Crunchbase Company Profile
Gate Neurosciences is a healthcare company that offers neuroscience-related medical services. The company is developing the next-generation of targeted CNS therapies, leveraging precision medicine approaches to develop …See details»
Gate Neurosciences - LinkedIn
Gate Neurosciences | 1,401 followers on LinkedIn. Brain Health, Reimagined | We're on a mission to develop a new generation of brain health therapies for the ~1 billion people worldwide suffering ...See details»
Gate Neurosciences - Contact Us
Gate Neurosciences is a clinical-stage biotechnology company using precision medicine to develop a new generation of therapies that enhance synaptic function for the 1 billion people …See details»
Gate Neurosciences Emerges from Stealth with a Portfolio of Next ...
Aug 23, 2022 Corporate Contact: Rob Houghtaling Senior Director, Corporate Development Gate Neurosciences, Inc. [email protected] Social Media Profiles Gate …See details»
Gate Neurosciences - Overview, News & Similar companies
Gate Neurosciences contact info: Phone number: (317) 652-1840 Website: www.gateneuro.com What does Gate Neurosciences do? We're on a mission to answer the unmet needs of people …See details»
Gate Neurosciences - PitchBook
Gate Neurosciences General Information Description. Developer of neuronal therapeutics designed to treat central neurologic and psychiatric disorders. The company's therapies are …See details»
Gate Neurosciences Emerges from Stealth with a Portfolio of Next ...
Aug 23, 2022 Further details on the company’s portfolio may be found on Gate’s website, gateneuro.com. About Gate Neurosciences. Gate Neurosciences is a precision medicine …See details»
Gate Neurosciences to Share New Data and Research Insights on …
INDIANAPOLIS, May 15, 2024--Gate will host its 3rd annual R&D Day with investigators and KOLs to share new insights ahead of an upcoming Phase 2 MDD study with zelquistinel.See details»
Gate Neurosciences - Our Approach
Gate Neurosciences is a clinical-stage biotechnology company using precision medicine to develop a new generation of therapies that enhance synaptic function for the 1 billion people …See details»
Michael McCully - Co-Founder, President & CEO - Apollo.io
Gate Neurosciences is on a mission to develop a new generation of therapies for the hundreds of millions of people worldwide suffering from neuropsychiatric and cognitive disorders.We are …See details»
Gate Neurosciences Hones in on Precision Medicine with …
May 3, 2023 Research focused on advancing translational qEEG biomarkers, dosing, and mechanism insights underlying Gate’s synaptic function-enhancing molecules.See details»
Gate Neurosciences to Share New Data and Research Insights on …
May 15, 2024 Gate will host its 3rd annual R&D Day with investigators and KOLs to share new insights ahead of an upcoming Phase 2 MDD study with zelquistinel.See details»
Gate Neurosciences Publishes Data Highlighting Novel
Sep 29, 2022 Corporate Contact: Rob Houghtaling - Sr. Director, Corporate Development Gate Neurosciences, Inc. [email protected] Release Summary New publication …See details»
Press Releases | Gate Neurosciences emerges from stealth with a ...
Click here for link to press release on businesswire CARMEL, Ind., August 23, 2022 - Gate Neurosciences today announced it has officially launched to develop its next-generation …See details»
Gate Neurosciences - Pipeline & Clinical Studies
The NMDA receptor is a key receptor for glutamate, the brain's primary excitatory neurotransmitter, and it plays a central role in regulating synaptic plasticity, learning/memory, …See details»
Gate Neurosciences to Highlight New Biomarker Data ... - Business …
May 24, 2023 Highlighting new biomarker data and research supporting precision development of the “‘stinel” class at the 2023 ASCP Annual Meeting; Gate’s Head of Research, Dr. Jeffrey …See details»
Gate Neurosciences - News
Gate Neurosciences is a clinical-stage biotechnology company using precision medicine to develop a new generation of therapies that enhance synaptic function for the 1 billion people …See details»
Gate Neurosciences Announces Positive Topline Human EEG …
Nov 7, 2023 The dose-dependent increase in qEEG biomarkers of NMDA receptor target activation from baseline was consistent a prior Phase 2a depression study.See details»